CDK 4/6 Inhibitor Palbociclib (PD0332991) in Rb+ Advanced Breast Cancer: Phase II Activity, Safety, and Predictive Biomarker Assessment
2014 · Clinical Cancer Research · 341 citations
https://doi.org/10.1158/1078-0432.ccr-14-2258
M
Mark Rosen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
323
Papers
11.2K
Citations
54
h-index
138
i10-index
Mark Rosen is an academic researcher from Amgen (United States). The author has contributed to research in topics: MRI in cancer diagnosis & Radiomics and Machine Learning in Medical Imaging & Advanced MRI Techniques and Applications. The author has an h-index of 54, co-authored 275 publications.
Papers by this author
worksPlatinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation
2019 · British Journal of Cancer · 195 citations
https://doi.org/10.1038/s41416-019-0582-7
Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)
2013 · Annals of Surgical Oncology · 110 citations
https://doi.org/10.1245/s10434-013-3038-y
Test–retest repeatability and reproducibility of ADC measures by breast DWI: Results from the ACRIN 6698 trial
2018 · Journal of Magnetic Resonance Imaging · 105 citations
https://doi.org/10.1002/jmri.26539
Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIAL
2020 · npj Breast Cancer · 78 citations
https://doi.org/10.1038/s41523-020-00203-7
Macroscopic optical physiological parameters correlate with microscopic proliferation and vessel area breast cancer signatures
2015 · Breast Cancer Research · 27 citations
https://doi.org/10.1186/s13058-015-0578-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat